BOXIT

A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder

Existing samples:

  • Carcinoma in situ of bladder (disorder)

Contact Information

Email:
boxit-icrctsu@icr.ac.uk
Address:

ICR-CTSU, Division of Clinical Studies
Sir Richard Doll Building
Cotswold Road
Sutton
 Surrey
Surrey
SM2 5NG
England

Last Updated: 10/30/2019


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A
2022 N/A N/A N/A N/A N/A N/A
2023 N/A N/A N/A N/A N/A N/A
2024 N/A N/A N/A N/A N/A N/A
2025 N/A N/A N/A N/A N/A N/A